CPCA Coding for Facial Injections 5 — Questions and Answers
Question 1: Which of the following best describes the National Correct Coding Initiative (NCCI) edit that most commonly affects facial injection coding?
- Bundling of the injection code with evaluation and management when a modifier is not applied (Correct answer)
- Automatic denial of all cosmetic injection codes
- Combining 11950 and 64615 into a single payment
- Requiring prior authorization for all filler codes
Correct answer: Bundling of the injection code with evaluation and management when a modifier is not applied
NCCI edits bundle certain procedure codes with E/M services unless Modifier 25 is appended to show a distinct, separately identifiable service.
Question 2: A patient receives masseter botulinum toxin injections for documented temporomandibular joint (TMJ) disorder. Which ICD-10-CM code best supports medical necessity?
- M26.60 (TMJ disorder, unspecified) (Correct answer)
- K08.9 (disorder of teeth, unspecified)
- L57.0 (actinic keratosis)
- Z41.1 (cosmetic encounter)
Correct answer: M26.60 (TMJ disorder, unspecified)
M26.60 classifies temporomandibular joint disorder and provides medical justification for chemodenervation of the masseter muscle.
Question 3: When reporting botulinum toxin for hyperhidrosis of the face, which CPT code is used?
- 64650 (Correct answer)
- 64615
- 11950
- 96372
Correct answer: 64650
CPT 64650 covers chemodenervation of eccrine glands for treatment of hyperhidrosis, distinct from muscle-targeted chemodenervation codes.
Question 4: Under Medicare, botulinum toxin injections for cosmetic purposes such as forehead rhytides are classified as:
- Non-covered services excluded from the Medicare benefit (Correct answer)
- Covered with prior authorization
- Covered under the preventive care benefit
- Covered when performed by a physician specialist
Correct answer: Non-covered services excluded from the Medicare benefit
Medicare explicitly excludes cosmetic procedures, including botulinum toxin for wrinkles, from coverage as they lack medical necessity.
Question 5: What does the place-of-service (POS) code 11 versus POS 22 indicate on a facial injection claim, and why does it matter?
- POS 11 (office) vs. POS 22 (on campus outpatient hospital) affects reimbursement rates and facility fee eligibility (Correct answer)
- POS codes have no impact on injection claims
- POS 22 always pays more than POS 11 for injectables
- They indicate the type of anesthesia used during the procedure
Correct answer: POS 11 (office) vs. POS 22 (on campus outpatient hospital) affects reimbursement rates and facility fee eligibility
The POS code determines whether a facility fee can be billed separately and affects the applicable fee schedule, which can significantly impact total reimbursement.
Question 6: A patient requests both dermal filler and neurotoxin injections at the same visit. The physician documents each procedure separately. How should these be reported?
- Report both 11950 (filler) and 64615 (neurotoxin) as separate line items with appropriate diagnoses linked to each (Correct answer)
- Report only the higher-paying code per NCCI guidelines
- Use a single unlisted code to capture both procedures
- Report 11950 with modifier 51 appended to 64615
Correct answer: Report both 11950 (filler) and 64615 (neurotoxin) as separate line items with appropriate diagnoses linked to each
Filler and neurotoxin injections are distinct procedures with separate CPT codes and can be reported together when each is fully documented.
Question 7: Which of the following scenarios would require an Advance Beneficiary Notice (ABN) for a Medicare patient seeking facial injections?
- When the provider believes Medicare will deny the injection as cosmetic or not medically necessary (Correct answer)
- When the injection takes more than 30 minutes to perform
- When the patient requests a specific brand of filler
- When the procedure is performed in an outpatient hospital setting
Correct answer: When the provider believes Medicare will deny the injection as cosmetic or not medically necessary
An ABN must be issued when Medicare is expected to deny payment so the patient can make an informed decision about financial responsibility.
CPCA Coding for Facial Injections 5
Which of the following best describes the National Correct Coding Initiative (NCCI) edit that most commonly affects facial injection coding?